참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Chlorotrimethylsilane | HCID 6397 | — |
| 반응물 | 2-Methylimidazole | HCID 12749 | — |
| 반응물 | Dipiperidinomethane | HCID 70151 | — |
| 반응물 | 9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one | HCID 598875 | — |
| 용매 | Water | HCID 962 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | Ondansetron | HCID 4595 | 68% |
반응 단계
2.0 g of 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one, 1.65 g of 2-methyl imidazole and 2.74 g of dipiperidinomethane were suspended in 20 ml of N,N-dimethylformamide, and then 4 ml of chlorotrimethylsilane was slowly added thereto. The reaction mixture was stirred for 8 hours at 90° C. 100 ml of water was added to the reaction mixture. The resulting solid was filtered and dried, which was then suspended in acetone and stirred for 3 hours, and then filtered and dried under a reduced pressure to give 1.99 g of title compound (yield 68%).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07521565B2 |
|---|
| 출처 데이터셋 | uspto-grants-2009_04 |
|---|
| ORD ID | ord-1d349961fb0e473ea1aeea743bc6ffe0 |
|---|
| 출처 메모 | uspto-grants-2009_04 |
|---|